Claritin and Kyprolis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claritin (loratadine) and Kyprolis (carfilzomib). Common drug interactions include immunosuppression among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Claritin and Kyprolis. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.

What is Kyprolis?

Kyprolis has active ingredients of carfilzomib. It is often used in multiple myeloma. eHealthMe is studying from 15,080 Kyprolis users. Check the latest studies of Kyprolis.



On Aug, 10, 2026

67 people who take Claritin and Kyprolis together, and have interactions are studied.

Claritin and Kyprolis drug interactions.

What are the common drug interactions of Claritin and Kyprolis, by gender? *:

female:

  1. Immunosuppression
  2. Infection
  3. Muscle spasms (muscle contraction)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Myocardial oedema (heart muscle swelling)
  6. Nausea (feeling of having an urge to vomit)
  7. Oxygen saturation decreased
  8. Papule
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Pathological fracture (broken bone caused by disease)

male:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Dry skin
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Intestinal obstruction
  6. Myalgia (muscle pain)
  7. Nausea (feeling of having an urge to vomit)
  8. Neuralgia (pain in one or more nerves)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

What are the common drug interactions of Claritin and Kyprolis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Fatigue (feeling of tiredness)
  2. Arthralgia (joint pain)
  3. Back pain
  4. Blood calcium decreased
  5. Body height decreased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cervical vertebral fracture
  8. Constipation
  9. Decreased appetite
  10. Diarrhoea

60+:

  1. Pneumonia
  2. Fatigue (feeling of tiredness)
  3. Migraine (headache)
  4. Urinary tract infection
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. Dyspnoea (difficult or laboured respiration)
  7. Erythema (redness of the skin)
  8. Eye swelling
  9. Flushing (the warm, red condition of human skin)
  10. Full blood count decreased

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Kyprolis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Claritin and Kyprolis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kyprolis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kyprolis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and carfilzomib (the active ingredients of Claritin and Kyprolis, respectively), and Claritin and Kyprolis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: